What is it?
Psilocybe semilanceata, commonly known as the Liberty Cap, is one of the most potent naturally occurring
psilocybin species, native to temperate grasslands across Europe and North America.
**Taxonomy and Classification**
- Kingdom: Fungi
- Phylum: Basidiomycota
- Class: Agaricomycetes
- Order: Agaricales
- Family: Hymenogastraceae
- Genus: Psilocybe
- Species: P. semilanceata (Fr.) P. Kumm., 1871
- Historical names: *Agaricus semilanceatus* Fr. (1838), *Panaeolus semilanceatus*, *Stropharia semilanceata*
**Etymology**
- *Psilocybe*: Greek "psilos" (bare) + "kube" (head) = "smooth head"
- *semilanceata*: Latin "semi" (half) + "lanceata" (spear-shaped)
- "Liberty Cap": Named for resemblance to the Phrygian cap, a symbol of freedom
**Physical Description**
- Cap: 5–25mm diameter, sharply conical/bell-shaped with distinctive nipple-like papilla
- Color: Pale brown to chestnut when moist; cream/ivory when dry (hygrophanous)
- Gills: Adnexed, cream to purple-brown with spore maturation
- Stem: 4.5–14cm long, 1–3.5mm thick; slender, often wavy
- Spore print: Dark reddish purple-brown to black
- Bruising: May stain bluish (indicates psilocybin)
**Geographic Distribution**
- Europe (native): UK (abundant), Ireland, Scandinavia, Netherlands, Czech Republic, Germany, France
- North America: Pacific Northwest (west of Cascades); rare elsewhere
- Other regions: Chile, Australia, New Zealand, India (Assam)
- Habitat: Grasslands, meadows, pastures; acidic, nutrient-poor soil; never directly on dung
- Season: September–November after rainfall; ends at first hard frost
**Why Suitable for Microdosing**
1. High potency: Higher psilocybin concentration means smaller quantities needed
2. Relatively consistent: Described as "most constant in psilocybin levels" (Beug & Bigwood)
3. Small size: Individual mushrooms weigh little, facilitating small measurements
4. Primarily psilocybin: Contains mainly psilocybin with trace psilocin, potentially more predictable
**Differences from P. cubensis**
| Feature | P. semilanceata | P. cubensis |
|---------|-----------------|-------------|
| Size | Small (cap 5–25mm) | Large (cap 2–8cm) |
| Habitat | Temperate grasslands | Tropical; grows on dung |
| Cultivation | Impossible | Easy |
| Psilocybin | 0.8–1.8% | 0.44–1.35% |
| Availability | Wild-harvested only | Widely cultivated |
🚨 Important Warnings
Please read all warnings carefully before use.
Higher potency than P. cubensis (1.5-2×). Reduce microdose by 50% compared to cubensis. Start with 0.05g and assess effects before increasing.
Species misidentification can be FATAL. Cortinarius rubellus has caused kidney failure requiring transplant. Expert identification is essential for wild-harvested specimens.
NEVER combine psilocybin with lithium. Documented 47% seizure rate with 39% requiring emergency care, including some fatalities.
Potency varies 10-fold (0.17–2.37% psilocybin) between specimens. Always homogenize batches before dosing and use a precision scale (0.01g minimum).
Avoid use with personal history of psychosis, schizophrenia, or bipolar disorder. Family history of psychotic disorders is a relative contraindication.
Legal status varies by jurisdiction. P. semilanceata is controlled in most countries. Verify local laws before any activity.
This information is for educational and harm reduction purposes only, not medical advice. Always consult healthcare professionals before making decisions about substance use.
⚠️ Interactions & Combinations
Important information about drug interactions and combinations. Always consult a physician before combining.
Lithium
Seizures, adverse reactions
Johns Hopkins analysis (Nayak et al., 2021) of 62 reports found 47% involved seizures, 18% resulted in "bad trips," and 39% required medical attention. NEVER combine.
MAOIs (Monoamine Oxidase Inhibitors)
Potentiation, serotonin syndrome
MAOIs inhibit psilocin breakdown, causing prolonged and intensified effects with unpredictable potentiation and increased serotonin syndrome risk. Do not combine; 2+ week washout required.
Tramadol
Serotonin syndrome, seizures
Tramadol has serotonin reuptake inhibition and lowers seizure threshold, increasing both serotonin syndrome and seizure risk when combined with psychedelics.
SSRIs (Selective Serotonin Reuptake Inhibitors)
Diminished effects (5-HT2A downregulation)
SSRIs can blunt psilocybin effects by reducing 5-HT2A receptor availability. Studies show no serotonin syndrome when combined, but effects may be significantly reduced. Do not abruptly discontinue SSRIs to use psilocybin.
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
Diminished effects
Similar to SSRIs - may reduce psilocybin effects. Consult provider; taper recommended if discontinuing.
Tricyclic Antidepressants
Variable effects
Complex receptor interactions; use caution; medical supervision recommended.
Cannabis
Intensification, anxiety
Cannabis can unexpectedly intensify effects and increase anxiety or paranoia. Many adverse event reports involve polysubstance use including cannabis. Avoid, especially if inexperienced.
Stimulants
Cardiovascular stress
Additive heart rate and blood pressure increases. Avoid combination.
Antipsychotics
Blocks effects (5-HT2A antagonism)
Antipsychotics block 5-HT2A receptors and will prevent psilocybin effects. Can be used as "trip killers" in emergencies.
Benzodiazepines
May dampen effects
Can be used as rescue medication for severe anxiety during difficult experiences.
💊 Dosage Guidelines
Typical dosage ranges from sub-perceptual microdoses to full psychoactive doses
Microdose
0.1 g
Sub-perceptual
Threshold
0.2 g
First noticeable effects
Moderate
1.0 g
Full effects
Strong
2.0 g
Intense experience
🧪 Preparation
Preparation methods and handling tips for accurate dosing.
Capsule Method
The gold standard for microdosing P. semilanceata. Dried mushrooms are ground to powder and weighed into capsules for consistent, tasteless, portable doses.
Steps:
- Verify mushrooms are completely dry (cracker-dry, snap when bent)
- Grind dried mushrooms to fine, uniform powder using clean grinder
- Homogenize thoroughly—this normalizes potency variation between specimens
- Weigh precise amounts (0.05–0.15g for P. semilanceata microdose)
- Fill capsules consistently; tap to settle powder
- Store in airtight container with desiccant packet, in dark, cool location
- Label clearly with contents, date, and batch weight
Tea Method
Faster onset (15–30 min) compared to capsules. May reduce nausea for some users.
Steps:
- Weigh precise microdose amount (0.05–0.15g dried)
- Chop or grind mushrooms finely to increase surface area
- Heat water to 70–80°C (NOT boiling to minimize degradation)
- Steep mushroom material for 10–15 minutes
- Strain and consume liquid; optionally eat remaining material
- Optional: Add lemon juice during steeping (may accelerate conversion, faster onset)
Honey Preservation ("Blue Honey")
Honey acts as a natural preservative for long-term storage. Dosing is less precise than capsules due to variation in distribution.
Steps:
- Weigh total dried mushroom amount and calculate ratio (e.g., 10g mushrooms per 100g honey = 0.1g per 1g honey)
- Grind mushrooms to fine powder
- Mix thoroughly into raw honey until evenly distributed
- Store in sealed glass jar in dark, cool location
- Allow to infuse for 1–4 weeks, stirring occasionally
- Dose by weight of honey consumed (e.g., 1g honey = 0.1g mushroom in above ratio)
📋 Microdosing Protocols
Recommended protocols and regimens for microdosing this substance.
Fadiman Protocol
Dosage:
P. semilanceata: Start 0.05g dried; typical 0.05–0.15g. If you feel it, reduce.
Schedule:
1 day on, 2 days off
The most widely recommended starting protocol. Day 1: microdose in the morning. Day 2: transition day to observe residual effects. Day 3: baseline day. Repeat.
Detailed Schedule:
- Day 1: Take microdose in the morning with breakfast
- Day 2: Transition day - observe afterglow
- Day 3: Baseline day
- Day 4: Repeat cycle
Stamets Protocol (Stamets Stack)
Dosage:
P. semilanceata: 0.05–0.1g dried; lion's mane 50–200mg; niacin 25–50mg (flush).
Schedule:
4-5 days on, 2-3 days off
Combines psilocybin with lion's mane and niacin for hypothesized synergistic neurogenesis benefits. Best after completing 1-2 cycles of the Fadiman Protocol.
Detailed Schedule:
- Days 1-4: Take all three components each morning
- Days 5-7: Rest (optional lion's mane only)
- Repeat for 4-6 weeks
- Take a 2-6 week break before the next cycle
✨ Reported Effects
Cognitive Enhancement
Enhanced focus, improved problem-solving abilities, and greater mental clarity. While placebo-controlled research shows neurobiological changes, cognitive improvements in controlled studies remain inconsistent.
Mood Improvement
Observational studies found small- to medium-sized improvements in mood and mental health among microdosers. Users frequently describe reduced anxiety and elevated mood.
Creativity and Divergent Thinking
Enhanced creative output and novel thinking patterns. Psilocybin decreases activity in the Default Mode Network (DMN), potentially allowing for more flexible cognitive patterns.
Increased Neuroplasticity
Research demonstrates psilocybin promotes structural and functional neuroplasticity: increased BDNF expression, enhanced dendritic spine density, and TrkB/mTOR pathway activation.
⚠️ Safety Information
Psilocybin has a favorable physiological safety profile with no evidence of organ damage at normal doses
and a wide therapeutic index (lethal doses estimated >1000× therapeutic). Psychological risks include
transient anxiety and the potential to trigger latent psychiatric conditions in susceptible individuals.
**P. semilanceata's high potency requires particularly conservative initial dosing**—start with 0.05g dried
and assess effects before increasing. Accurate species identification is critical as poisonous look-alikes
exist, including the potentially deadly Cortinarius rubellus which has caused kidney failure requiring
transplant.
ABSOLUTE CONTRAINDICATIONS: Never combine with lithium (47% seizure rate documented). Avoid with personal
history of psychosis, schizophrenia, or bipolar disorder.
Use only in stable mental states in safe, comfortable settings. Allow 24+ hours before driving or
important decisions. Individual responses vary significantly.
🔬 Scientific Research
Current research findings and clinical studies.
No significant differences between microdose and placebo groups; benefits may be explained by placebo effect.
Small-medium improvements in mood; Stamets Stack improved psychomotor performance in adults 55+.
No significant effects on cognition or creativity; EEG changes observed.
71% showed >50% depression reduction at 4 weeks; 54% in remission.
Connectivity changes persisted for weeks after single 25mg dose.
No overall cognitive benefit (d = −0.06); selective reduction in cognitive control.
⚖️ Legal Status
Current legal status in various jurisdictions. Always respect local laws.
| Jurisdiction | Status | Details |
|---|---|---|
|
United States (Federal)
(1970) |
Schedule I - Illegal
|
Classified as Schedule I under the Controlled Substances Act (1970). Possession up to 1 year; distribution is felony. State exceptions: Oregon (therapy legal, 2020), Colorado (decriminalized, 2022), New Mexico (medical, 2025). City decriminalization: Denver, Oakland, Santa Cruz, Washington D.C., Ann Arbor, Seattle, others. |
|
Netherlands
(2008) |
Mushrooms illegal / Truffles LEGAL
|
Psilocybin mushrooms illegal since December 2008. Truffles (sclerotia) remain LEGAL (not included in Opium Act). Smart shops openly sell fresh truffles. Personal possession up to 0.5g dried/5g fresh tolerated. |
|
Czech Republic
(2025) |
Medical use legalized (effective 2026)
|
Decriminalized for personal use since 2010. Medical psilocybin legalized July 17, 2025 (effective January 1, 2026). First EU nation to legislate medical psilocybin. Medical access for treatment-resistant depression, PTSD; certified psychiatrists only. |
|
Canada
(1974) |
Schedule III - Illegal with exemptions
|
Controlled substance with legal access via Section 56 exemptions and Special Access Programme. Penalties: up to 3 years (possession); 10 years (trafficking). Grey market: 57+ dispensaries operating as of 2024. |
|
United Kingdom
(1971) |
Class A - Illegal
|
Class A under Misuse of Drugs Act 1971. Fresh mushrooms made illegal July 18, 2005 (Drugs Act 2005). Penalties: up to 7 years (possession); life (supply). Research requires Schedule 1 Home Office license. |
|
Portugal
(2001) |
Decriminalized
|
All drugs decriminalized for personal use since 2001. |
| Jamaica |
Legal (never prohibited)
|
Psilocybin mushrooms were never prohibited in Jamaica. Fully legal. |
| Brazil |
Effectively legal (not scheduled)
|
Psilocybin is not scheduled in Brazil. |
|
Australia
(2023) |
Medical legal (July 2023)
|
Medical psilocybin legal since July 2023 for treatment-resistant depression. |
|
Germany
(2025) |
Compassionate use programme (July 2025)
|
Compassionate use programme established July 2025. |
👤 Key Figures
Notable figures associated with the research and history of this substance.
Gastón Guzmán
Mycologist, taxonomist
Authored major taxonomic works on the Psilocybe genus.
Elias Magnus Fries
Swedish mycologist; "The Linnaeus of Mycology"
First scientifically described P. semilanceata as *Agaricus semilanceatus* in *Epicrisis Systematis Mycologici* (1838). Developed foundational fungal classification system; described hundreds of species.
Roger Heim
Mycologist
Co-authored early scientific studies on psilocybin mushrooms and advanced classification of the genus.
Albert Hofmann
Swiss chemist at Sandoz Laboratories
Synthesized LSD (1938); discovered its effects (1943). Isolated and synthesized psilocybin and psilocin (1958). First to confirm psilocybin in P. semilanceata (1963) - the first European species identified.
R. Gordon Wasson
VP at J.P. Morgan; ethnomycologist
1957 Life magazine article "Seeking the Magic Mushroom" introduced psychedelic mushrooms to Western audiences; participated in María Sabina's ceremonies (1955). Founded ethnomycology as field. Coined "Magic Mushroom" (unintentionally).
James Fadiman
Psychologist; "Father of Modern Microdosing"
Developed the Fadiman Protocol (1 day on, 2 days off); published *The Psychedelic Explorer's Guide* (2011). Collected thousands of microdosing self-reports; formalized protocol based on anecdotal data.
Paul Stamets
Mycologist; founder of Fungi Perfecti and Host Defense
*Psilocybin Mushrooms of the World* (1996). Developed the Stamets Stack (psilocybin + Lion's Mane + niacin). Holds 3 composition patents on psilocybin discoveries. First recipient of Gordon and Tina Wasson Award (2015); species *Psilocybe stametsii* named in his honor.
📚 Scientific Research
PubMed
Primary database for peer-reviewed biomedical literature. Search: "psilocybin microdosing" OR "Psilocybe semilanceata"
https://pubmed.ncbi.nlm.nih.gov/Johns Hopkins Center for Psychedelic & Consciousness Research
150+ peer-reviewed publications; leading U.S. institution. Founded by Dr. Roland Griffiths.
https://hopkinspsychedelic.org/Imperial College London Centre for Psychedelic Research
Self-blinding study; psilocybin vs. escitalopram trial. Researchers: David Nutt, Robin Carhart-Harris.
https://www.imperial.ac.uk/psychedelic-research-centreMAPS (Multidisciplinary Association for Psychedelic Studies)
Nonprofit supporting psychedelic research since 1986.
https://maps.org/Erowid Psilocybin Vault
Experience reports, chemistry, and long-standing harm reduction resource.
https://www.erowid.org/plants/mushrooms/mushrooms.shtmlPsychedelic Alpha
Industry and research news tracking; legal status tracker across jurisdictions.
https://psychedelicalpha.com/❓ FAQ
How long until effects begin?
Oral microdoses typically begin within **20–60 minutes**, though this varies with stomach contents.
Empty stomach accelerates onset; food delays it. Tea preparations may produce effects within 15–30 minutes.
How should P. semilanceata be stored?
Properly dried mushrooms (<10% moisture) should be stored in **airtight containers** in a **dark, cool
location** (15–21°C). Vacuum sealing extends shelf life. Avoid light, heat, and moisture. Properly stored,
potency can be retained for 6–12 months; some specimens retain 50% potency after 5 years.
How does P. semilanceata differ from other psilocybin mushrooms?
P. semilanceata is **1.5–2× more potent** than common P. cubensis, requiring proportionally lower doses.
It grows only in wild temperate grasslands (cannot be cultivated), has a distinctive conical cap with
papilla, and contains primarily psilocybin with only trace psilocin.
Can it be combined with supplements?
The **Stamets Stack** combines psilocybin with Lion's Mane mushroom (50–200mg) and niacin (25–50mg).
Research (Rootman et al., 2022) found adults 55+ showed improved psychomotor performance with this
combination. However, **avoid combining with lithium (seizure risk), MAOIs (potentiation), or St. John's Wort**.
How do you assess quality?
Quality indicators include: proper drying (cracker-dry, brittle stems), consistent color (pale brown/cream),
intact papilla, no mold or discoloration, characteristic flour-like odor. For wild-harvested specimens,
**expert identification is essential**—poisonous look-alikes can be fatal.
What's the potency difference between fresh and dried?
Fresh mushrooms contain approximately **90% water**. The rule of thumb: **10g fresh ≈ 1g dried**. Dried
mushrooms have 10× higher psilocybin concentration per gram. Fresh specimens may have slightly higher
psilocin content but degrade rapidly (24–48 hours at room temperature).
Are there dangerous look-alikes?
Yes. **Cortinarius rubellus** (Deadly Webcap) has caused kidney failure requiring transplant when confused
with P. semilanceata. **Galerina** species contain deadly amatoxins. Key identifying features for
P. semilanceata: conical cap with papilla, hygrophanous (color changes wet/dry), purple-brown spore print,
grassland habitat (never on wood or dung).
Important Legal Notice
⚠️ Personal Responsibility
You use this application entirely at your own risk and responsibility. MicrodosingDiary is only a tool for recording personal experiences.
🚫 Not a Medical Service
This application IS NOT a medical tool, does not provide medical advice, does not diagnose or treat any conditions. Always consult a qualified physician.
⚖️ Legislation and Laws
Many substances used for microdosing are illegal in many countries. Users are fully responsible for complying with local laws. The application does not support or promote illegal activity.
❌ No Guarantees
We provide no guarantees regarding results, safety or efficacy of microdosing. All information is for informational purposes only.
🔞 Age Restriction
Application is intended only for persons over 18 years of age. By using the application you confirm that you are an adult.
🔒 Data Privacy
Your data is private and encrypted. We never share it with third parties without your consent. Application is for personal use only.
By using this application you accept all the above risks and waive any claims against the application operator.